Immunotherapy before surgery shows promise for oral cancer
Disease control
Not yet recruiting
This study tests whether giving the immunotherapy drug nivolumab before surgery can shrink advanced oral cancer tumors. About 60 adults with resectable oral squamous cell carcinoma will receive nivolumab, then have surgery. Researchers will also look for biomarkers in lymph nodes…
Phase: PHASE2 • Sponsor: Prof. Lars Olaf Cardell • Aim: Disease control
Last updated May 15, 2026 11:53 UTC